Literature DB >> 22574967

The role of diabetes on the clinical manifestations of pulmonary tuberculosis.

Daniel Faurholt-Jepsen1, Nyagosya Range, George PrayGod, Kidola Jeremiah, Maria Faurholt-Jepsen, Martine G Aabye, John Changalucha, Dirk L Christensen, Henrik Krarup, Daniel R Witte, Aase B Andersen, Henrik Friis.   

Abstract

OBJECTIVE: Diabetes is associated with pulmonary tuberculosis (TB), possibly due to impaired immunity, and diabetes may exacerbate the clinical manifestations of TB. Our aim was to assess the role of diabetes in the clinical manifestations of TB.
METHODS: We studied 1250 patients with pulmonary TB in an urban population in a cross-sectional study in Tanzania. All participants were tested for diabetes and HIV co-infection, and TB culture intensity was assessed. Levels of white blood cells, haemoglobin, acute phase reactants, CD4 count and HIV viral load were measured, and a qualitative morbidity questionnaire was used to identify the prevalence of disease-related symptoms.
RESULTS: Tuberculosis patients with diabetes had a higher neutrophil count (B 0.5 × 10(9) cells/l, 95% CI 0.2; 0.9, P = 0.001) than non-diabetic TB patients. Serum C-reactive protein (B 18.8 mg/l, CI 95% 8.2; 29.4, P = 0.001) and alpha-1-acid glycoprotein (B 0.2 g/l, CI 95% 0.03; 0.3, P = 0.02) were similarly higher in patients with diabetes. Diabetes did not affect culture intensity or HIV status, but self-reported fever was three times higher among participants with diabetes than in those without diabetes (OR 2.9, CI 95% 1.5; 5.7, P = 0.002).
CONCLUSION: Diabetes is associated with small changes in the manifestations of TB, but may have little clinical significance.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574967     DOI: 10.1111/j.1365-3156.2012.03002.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  14 in total

1.  Predictors of body composition changes during tuberculosis treatment in Mwanza, Tanzania.

Authors:  G PrayGod; N Range; D Faurholt-Jepsen; K Jeremiah; M Faurholt-Jepsen; M G Aabye; P Magnussen; J Changalucha; A B Andersen; J C K Wells; H Friis
Journal:  Eur J Clin Nutr       Date:  2015-04-01       Impact factor: 4.016

Review 2.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

3.  The impact of diabetes mellitus on pulmonary TB.

Authors:  Y M Zhang; F Wang; D van Soolingen; R M Anthony
Journal:  Public Health Action       Date:  2022-06-21

Review 4.  Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review.

Authors:  Marit Eika Jørgensen; Daniel Faurholt-Jepsen
Journal:  Curr Diab Rep       Date:  2014-07       Impact factor: 4.810

5.  Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy.

Authors:  Xiaolei Pan; Li Wang; Dirk Gründemann; Douglas H Sweet
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

6.  The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania.

Authors:  Daniel Faurholt-Jepsen; Nyagosya Range; George Praygod; Jeremiah Kidola; Maria Faurholt-Jepsen; Martine Grosos Aabye; John Changalucha; Dirk Lund Christensen; Torben Martinussen; Henrik Krarup; Daniel Rinse Witte; Åse Bengård Andersen; Henrik Friis
Journal:  BMC Infect Dis       Date:  2012-07-27       Impact factor: 3.090

Review 7.  Endocrine dysfunction among adult patients with tuberculosis: An African experience.

Authors:  Davis Kibirige
Journal:  Indian J Endocrinol Metab       Date:  2014-05

8.  Chronic diseases and multi-morbidity--a conceptual modification to the WHO ICCC model for countries in health transition.

Authors:  Tolu Oni; Nuala McGrath; Rhonda BeLue; Paul Roderick; Stephen Colagiuri; Carl R May; Naomi S Levitt
Journal:  BMC Public Health       Date:  2014-06-09       Impact factor: 3.295

9.  Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand.

Authors:  D Duangrithi; V Thanachartwet; V Desakorn; P Jitruckthai; K Phojanamongkolkij; S Rienthong; C Chuchottaworn; P Pitisuttithum
Journal:  Int J Clin Pract       Date:  2013-06-10       Impact factor: 2.503

10.  Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia.

Authors:  Mahteme Haile Workneh; Gunnar Aksel Bjune; Solomon Abebe Yimer
Journal:  Infect Dis Poverty       Date:  2016-03-21       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.